Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VaxThera's Yellow Fever Vaccine is a preclinical candidate designed to provide protective immunity against the yellow fever virus. Developed by the Colombian biotech company VaxThera in partnership with the University of Wisconsin and the Universidad Nacional de Colombia, the vaccine leverages both viral vector and mRNA technology platforms. This dual-platform approach aims to optimize the immune response, potentially offering improved safety or efficacy over traditional live-attenuated vaccines. The project is co-funded by the Colombian Ministry of Science, Technology, and Innovation (MinCiencias).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yellow Fever Vaccine (VaxThera).